Back

Phosphoinositide 3-kinase gamma inhibition protects against anthracycline-induced cardiomyopathy by boosting cardiac autophagy

8 July 2016 (15:30 - 15:45)
Organised by: Logo
Congress Presentation Part of: Young investigator award session - Heart Cell death / apoptosis / autophagy - Heart Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

About the speaker

Photo
Mr Mingchuan Li

University of Turin, Turin (Italy)

5 More presentations in this session

Presentation thumbnail
Targeting the miRNA-106b-25 cluster as a potential regenerative therapeutic approach for myocardial injury
Doctor E. Dirkx (Maastricht, NL)
Abstract
Presentation thumbnail
An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model
Mr I. Perea Gil (Badalona, ES)
Abstract Slides
Presentation thumbnail
Functional screening of microRNAs identifies miR-22 as a regulator of cardiac autophagy and aging
Doctor S. Gupta (Lucknow, IN)
Abstract Slides
Presentation thumbnail
Functional defects and molecular mechanisms of left ventricular non-compaction in nkx2.5 mutant mice
Miss T. Nguyen (Marseille, FR)
Abstract
Presentation thumbnail
PITX2 modulates atrial membrane potential, potentiating the antiarrhythmic effects of sodium channel blockers
Doctor F. Syeda (Birmingham, GB)
Abstract

Access the full session

Session thumbnail
Young investigator award session - Heart

The Event

Event poster

Frontiers in CardioVascular Biology 2016

8 July 2016 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Unveiling doxorubicin-induced cardiotoxicity: into the heart with single-cell resolution
20 June 2025
thumbnail
Congress Presentation
Circulating markers of autophagy dysfunction are associated with coronary artery disease in patients undergoing coronary angiography
1 September 2025
thumbnail
Congress Presentation
Cardioprotective effects of prophylactic ACE Inhibitors in anthracycline-based chemotherapy: a systematic review and meta-analysis
4 April 2025
thumbnail
Congress Presentation
Polydatin, a nutraceutical agent, reduces cardiotoxicity and enhances the anticancer effects of Sunitinib through the reduction of lipid peroxidation and expression of NLRP3 inflammasome
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources